Toyosato, Japan

Tohru Fujimori

This inventor holds 12 USPTO granted patents. Top assignees: Eisai Company, Limited, Nagoya University. Active years: 1988-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tohru Fujimori. Retrieved from https://idiyas.com/inventor/tohru-fujimori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.5

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • Tsukuba, JP (1989 - 1991)
  • Toyosatomachi, JP (1988 - 1992)
  • Toyosato, JP (1990 - 1993)
  • Tenafly, NJ (US) (1997)

Company Filing History:


Years Active: 1988-1997

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Tohru Fujimori: Innovator in Pharmaceutical Chemistry

Introduction

Tohru Fujimori is a prominent inventor based in Toyosato, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 12 patents. His work focuses on developing novel compounds that have therapeutic applications, particularly in treating cardiovascular diseases.

Latest Patents

Fujimori's latest patents include innovative compounds such as trisubstituted benzene derivatives. These compounds are recognized for their potential as anti-arteriosclerotic agents. The specific formula involves various substituents that enhance the compound's efficacy. Another notable patent involves diphenylethylene derivatives, which are useful in inhibiting blood agglomeration. These compounds are defined by specific chemical structures that include diphenyl-methane derivatives and benzophenone oxime derivatives.

Career Highlights

Throughout his career, Tohru Fujimori has worked with esteemed organizations such as Eisai Company, Limited and Nagoya University. His research has led to advancements in drug development, particularly in the area of cardiovascular health. His innovative approach to pharmaceutical chemistry has garnered attention in the scientific community.

Collaborations

Fujimori has collaborated with notable colleagues, including Shinya Abe and Isao Yamatsu. These partnerships have contributed to the success of his research and the development of new pharmaceutical compounds.

Conclusion

Tohru Fujimori's contributions to pharmaceutical chemistry are significant, with a focus on developing innovative compounds for treating cardiovascular diseases. His work continues to impact the field and offers promising avenues for future research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…